Journal of Bioequivalence & Bioavailability

Gene Therapy and it’s recent application

10^th World Congress on Bioavailability and Bioequivalence

April 08-09, 2019 Abu Dhabi, UAE

Said Abdel Karim Abdel Hamid Mohamed

SEHA-Ambulatory Healthcare Services, UAE

Scientific Tracks Abstracts: J Bioequiv Availab

Abstract:

Gene therapy is one of the most advanced ways in treateting the most untreatable diseases and it;s simply when DNA is introduced into a patient to treat a genetic disease. The new DNA usually contains a functioning gene to correct the effects of a disease-causing mutation.Sometimes the whole or part of a gene is defective or missing from birth, or a gene can change or mutate during adult life. Any of these variations can disrupt how proteins are made, which can contribute to health problems or diseases. In this presentation we will illustrate the baiscs of gene therapy and the most recent approved gene therapy products.

Biography :

Said is working as a clinical staff lead pharmacist with more than 8 years of experience as Hospital pharmacist, furthermore he worked as a Teaching Aids at Al Ahram Canadian university Egypt, as well as drug control specialist in antibiotics department at NODCAR (the national organization for drug control & research) currently he is working as pharmacist lead in Ambulatory Healthcare Services-SEHA, Participated in many local and international conferences, Said has certified as American board pharmacotherapy specialist (BCPS). He got his M.Sc. in clinical pharmacy in 2014 and in 2015 got his MBA from Torrens university/Abu Dhabi.

E-mail: skhmohamed@seha.ae